Cutler Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-700
| Closed | -$482K | – | 2235 |
|
|
2022
Q3 | $482K | Buy |
700
+528
| +307% | +$364K | 0.03% | 270 |
|
|
2022
Q2 | $101K | Sell |
172
-1,800
| -91% | -$1.06M | 0.01% | 670 |
|
|
2022
Q1 | $1.38M | Buy |
+1,972
| New | +$1.38M | 0.07% | 169 |
|
|
2020
Q1 | – | Sell |
-116
| Closed | -$43K | – | 1937 |
|
|
2019
Q4 | $43K | Buy |
+116
| New | +$43K | ﹤0.01% | 948 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 2002 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 2057 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2078 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 2076 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 2141 |
|
|
2018
Q1 | – | Sell |
-5,484
| Closed | -$2.06M | – | 2335 |
|
|
2017
Q4 | $2.06M | Buy |
5,484
+877
| +19% | +$330K | 0.08% | 129 |
|
|
2017
Q3 | $2.06M | Buy |
4,607
+1,209
| +36% | +$540K | 0.08% | 142 |
|
|
2017
Q2 | $1.67M | Sell |
3,398
-405
| -11% | -$199K | 0.06% | 192 |
|
|
2017
Q1 | $1.47M | Buy |
3,803
+703
| +23% | +$272K | 0.06% | 207 |
|
|
2016
Q4 | $1.14M | Buy |
3,100
+470
| +18% | +$172K | 0.04% | 266 |
|
|
2016
Q3 | $1.06M | Hold |
2,630
| – | – | 0.05% | 207 |
|
|
2016
Q2 | $918K | Sell |
2,630
-650
| -20% | -$227K | 0.05% | 208 |
|
|
2016
Q1 | $1.18M | Buy |
3,280
+2,030
| +162% | +$732K | 0.08% | 149 |
|
|
2015
Q4 | $678K | Buy |
+1,250
| New | +$678K | 0.04% | 309 |
|